Tri Star Advisors Inc. Coh Bar, Inc. Transaction History

Tri Star Advisors Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 Apr 29, 2022	SELL	$0.25 - $0.43 $8,452 - $14,538	-33,811 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$0.34 - $1.0 $11,495 - $33,811	33,811 New	33,811 $14,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.51M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Tri Star Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Tri Star Advisors Inc. with notifications on news.